Across TCGA pan-cancer cohorts, RNU6ATAC34P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNU6ATAC34P data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6ATAC34P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6ATAC34P expression acts as an unfavorable survival marker, although some lineages such as STAD and CESC show a favorable association.
STAD, ESCA, and OV are the cancer types where RNU6ATAC34P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.